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Objective: We sometimes experienced patients with primary unknown cervical lymph node
metastasis. In such cases, if computed tomography, magnetic resonance imaging, laryngo-
scopy and gastrointestinal endoscopy cannot detect a primary site, there is no other effective
method to identify a possible primary tumor. We investigated whether narrow-band imaging
can detect a possible primary tumor in such.
Methods: Forty-six patients with primary unknown cervical lymph node metastasis were sur-
veyed about primary tumors, from January 2003 to December 2006. All cervical lymph nodes
were histologically proved to be squamous cell carcinoma by ﬁne-needle aspiration cytology.
Narrow-band imaging combined with magnifying endoscopy was used to identify the primary
site in the head and neck region and cervical esophagus. Histological analysis was performed
for all suspicious lesions by a biopsy specimen.
Results: Twenty-six lesions were suspected to be cancerous lesions by narrow-band
imaging in the head and neck region. Sixteen lesions in 16 (35%, 16/46) patients were squa-
mous cell carcinoma. Ten lesions were located in the hypopharynx and the remaining six
lesions were located in the oropharynx. White light endoscopy could not point out any lesion.
Conclusions: Narrow-band imaging endoscopy can detect possible primary cancer in
patients with primary unknown cervical lymph node metastasis.
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INTRODUCTION
In the head and neck region, we sometimes treat patients
with cervical lymph node metastasis where a primary tumor
cannot be identiﬁed by laryngoscopy, computed tomography
(CT) and magnetic resonance imaging (MRI). Primary
unknown cervical lymph node metastasis (PUCLNM) is
reported in 2–9% of metastases in the head and neck region.
Additional work-up including upper gastrointestinal endo-
scopy can detect possible primary lesions in about 10% of
the patients, but the possible primary site is not identiﬁed in
90% of the patients with PUCLNM.
The inability to ﬁnd the primary tumor makes it difﬁcult
to decide on the most appropriate treatment for the patient,
and the clinician must consider different options for the
initial treatment. In some cases, the primary tumor is
detected during treatment for the lymph node metastasis, but
the primary site remains unidentiﬁed in some. In cases
where the primary tumor is detected after the start of
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stage and evaluate the treatment strategy, the clinician
should be able to detect the primary site before starting
treatment.
To ﬁnd a primary lesion, blind biopsy (1–3) or tonsil-
lectomy (4) is sometimes used in patients with PUCLNM.
However, these surveillance methods do not always detect
the primary lesion. In the case of PUCLNM, whole-neck
irradiation will be indicated after cervical lymph node
excision because we cannot pinpoint the primary cancer-
based treatment strategy (5–7). Whole-neck irradiation
causes adverse events such as salivary gland disorder,
severe mucositis and taste disorder. In addition, if primary
cancer could be detected after irradiation, re-irradiation
would not be needed; this is important because surgery
after irradiation increases the risk of leakage of the
anastomosis.
Muto et al. (8,9) reported that narrow-band imaging (NBI)
can detect superﬁcial cancer in the oropharynx and
hypopharynx. Although NBI is expected to help identify the
primary lesion in patients with PUCLNM, there are no
reports on this issue. We surveyed primary lesions in such
patients using NBI endoscopy of the gastrointestinal tract.
PATIENTS AND METHODS
From January 2003 to December 2006, 46 consecutive
patients with PUCLNM were surveyed about the primary
site using a gastrointestinal NBI endoscope in National
Cancer Center Hospital East, Chiba, Japan. Written informed
consent for the examination was obtained from all patients.
The deﬁnition of PUCLNM was in accordance with the
report by Greenberg (10) as follows.
† It is proven to have malignant cells histologically.
† We cannot identify a primary tumor using ocular inspec-
tion or pharyngolarynx ﬁberoscopy.
† We cannot identify a primary tumor by CT or MRI.
† Other organs except the head and neck do not show a
carcinoma.
In all patients, the possible primary tumor could not be
detected by examination using CT, MRI, pharyngolaryngo-
scopy and standard white-light gastrointestinal endoscopy.
We used a magnifying videoendoscope (Q240Z, Olympus
Medical Systems, Tokyo, Japan) and sequential RGB light
source with NBI function (CLV-Q260SL, Olympus Medical
Systems). The magnifying endoscope had a capability of
 80 optical magniﬁcation. The NBI system has been
described in detail in previous studies (8,9). In this system,
the central wavelengths of NBI were 415 and 540 nm, and
each had a bandwidth of 30 nm.
During the survey of the primary site in the head and neck
region including the cervical esophagus, if the lesions
showed both a well-demarcated brownish area and an irregu-
lar microvascular pattern (11), we diagnosed cancer. After
this examination, we took a biopsy specimen to conﬁrm the
histological diagnosis.
RESULTS
The patients’ characteristics are shown in Table 1.
Thirty-eight patients were men and eight were women. Their
median age was 66 years (range, 38–81 years).
Twenty-eight cases were N2 and 18 cases were N3.
Thirty-one patients had metastatic lymph nodes in the upper
jugular area (Level II), 13 had middle jugular lymph node
metastasis (Level III) and 2 had lower jugular lymph node
metastasis (Level IV).
Twenty-six lesions were suspected to be the cancerous site
in 25 patients. Sixteen lesions in 16 patients were conﬁrmed
histologically as squamous cell carcinoma. Histological
assessment of all of the possible primary lesions showed the
similar feature of squamous cell carcinoma. Thus, primary
cancer in the head and neck region was detected in 16
patients (35%) by NBI endoscopy. The patients’ character-
istics are shown in Table 2. Ten patients had metastatic
lymph nodes in the upper jugular area, ﬁve had middle
jugular lymph node metastasis and one had lower jugular
lymph node metastasis. Nine cases were N3 and seven cases
were N2. All of the lesions detected were superﬁcial neo-
plasia. Ten lesions were located in the hypopharynx and the
remaining six lesions were located in the oropharynx (three
were tonsil). All lesions were T1 stage or Tis, and all lesions
were ,2 cm in size. Biopsy specimens revealed that one
lesion was intraepithelial cancer and the other had invaded
to the subepithelial layer.
Table 1. Patient characteristics
Patients
Age (years) 66 (38–81)
Gender
Male 38
Female 8
N stage
N2a 4
N2b 20
N2c 4
N3 18
Levels of cervical metastasis
Upper jugular (II) 31
Middle jugular (III) 13
Lower jugular (IV) 2
Thirty-eight patients were males and eight were females. Median age was
65 years (range, 38–81 years). Twenty-eight cases were N2 and 18 cases
were N3. Thirty-one patients had metastatic lymph node in the upper jugular
area (Level II), 15 had middle jugular lymph node metastasis (Level III) and
2 cases had lower jugular lymph node metastasis (Level IV).
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therapy (CRT). Two patients were treated with a chemother-
apy regimen comprising 5-ﬂuorouracil (800 mg/m
2, days
1–5) and cisplatin (80 mg/m
2, day 1). Two patients were
treated with tegafur-gimeracil-oteracil potassium (60 mg/m
2,
days 1–14) and cisplatin (20 mg/m
2, day 1). One patient was
treated with cisplatin (80 mg/m
2, day 1). The irradiation ﬁeld
covered the whole neck, and the total radiation dose was
70 Gy (2 Gy/fr). Two patients were treated by radiation
therapy (total 70 Gy) alone. For the other nine patients, the
primary site was removed by surgery or endoscopic resection,
followed by neck dissection of the lymph node metastasis. No
patient received whole-neck irradiation after neck dissection.
Treatment of the 20 patients who cannot detect cancer
lesion were CRT (for N3 or N2b), and neck dissection and
close follow-up with NBI endoscopy (for N2a or N2b).
Figure 1 shows a representative case where the primary
cancer was detected by NBI. This patient had a swollen
l y m p hn o d e( 2 . 5c mi ns i z e )o nthe left side of the upper
jugular area (Level II) (Fig. 1). The specimen taken using a
ﬁne-needle aspiration method from the swollen lymph node
revealed squamous cell carcinoma, which was conﬁrmed
later as metastatic. CT scan, MRI, laryngoscopy and standard
gastrointestinal endoscopy could not detect any primary site.
NBI detected easily a well-demarcated brownish area in the
uvula to the right anterior palatine arch (Fig. 2B). In con-
trast, the conventional white-light image made it difﬁcult to
visualize the cancerous lesion (Fig. 2A). Magnifying the
observation with NBI revealed easily an irregular microvas-
cular pattern inside the lesion (Fig. 2D), but magnifying the
observation with white light made it difﬁcult to see this irre-
gular microvascular pattern (Fig. 2C). We diagnosed cancer
for this lesion. The biopsy specimen revealed squamous cell
carcinoma, which was similar histologically to that of the
metastatic lymph node. Treatment of this patient involved
neck dissection and resection for primary disease, and we
were able to avoid irradiation of the whole neck.
DISCUSSION
We report for the ﬁrst time that NBI endoscopy can detect
possible primary cancer in patients with PUCLNM.
Information about the primary site is very important for
deciding on the appropriate treatment because the treatment
strategy may differ for each primary site. Our data indicate
that NBI can be helpful to the clinician when deciding on
the treatment.
According to Greenberg (10), primary unknown carcinoma
is deﬁned when primary tumor cannot be detected by an
autopsy. However, this deﬁnition cannot be applied in clini-
cal decision-making. We deﬁned a PUCLNM as one for
which we could not detect any primary site by CT, MRI, lar-
yngoscopy and gastrointestinal endoscopy (11). Although
recent advance in technologies of CT, MRI and PET makes it
possible to detect a small lesion precisely, the primary cancer
is detected in only 2–9% of the patients with PUCLNM
(1,2,12,13). Positron emission tomography (PET) or CT is
also useful to detect occult cancer, but this primary site is too
small to point out with PET. Random biopsy in the head and
Table 2. Characteristics of possible primary lesions detected by NBI
Primary Endoscopic ﬁndings n (levels) Treatment
1 Oropharynx Superﬁcial 3 (II) CRT
2 Oropharynx T1 3 (II) CRT
3 Hypopharynx Superﬁcial 3 (II) RT
4 Oropharynx Superﬁcial 3 (III) CRT
5 Hypopharynx Superﬁcial 3 (II) CRT
6 Hypopharynx Superﬁcial 3 (II) EMR þ ND
7 Hypopharynx Superﬁcial 3 (II) CRT
8 Hypopharynx Superﬁcial 3 (II) Surgery þ ND
9 Oropharynx Superﬁcial 2b (III) Surgery þ ND
10 Oropharynx T1 2a (II) Surgery þ ND
11 Hypopharynx Superﬁcial 2b (IV) Surgery þ ND
12 Hypopharynx T1 2a (II) Surgery þ ND
13 Hypopharynx Superﬁcial 2b (II) EMR þ ND
14 Hypopharynx Superﬁcial 3 (III) RT
15 Oropharynx Superﬁcial 2c (II) Surgery þ ND
16 Hypopharynx Superﬁcial 2b (III) EMR þ ND
Nine cases were N3 and seven cases were N2. Five cases were treated by
concurrent chemoradiation therapy and in nine cases, primary site was
removed by surgery or endoscopic resection and they underwent neck
dissection for lymph node metastasis. NBI, narrow-band imaging; CRT,
chemoradiation therapy; EMR, endoscopic mucosal resection; ND, neck
dissection.
Figure 1. Computed tomographic scan shows lymph node metastasis at left
upper jugular area.
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cancer in patients with PUCLNM, but the detection rate is
only around 10% (1,2). However, tonsillectomy is very
useful to detect the primary cancer but tonsillectomy can
detect only tonsil cancer. Because only 3 of 16 cases have a
cancerous lesion on tonsil in this study, NBI endoscopy was
better than tonsillectomy to detect occult tumor.
In the esophagus, Lugol chromoendoscopy is useful for
detecting superﬁcial squamous cell carcinoma. However,
Lugol’s solution cannot be applied in the head and neck
region because of the risk of aspiration into the airway. NBI
is now recognized as a useful and safe method for detecting
superﬁcial squamous cell carcinoma in the head and neck
region because it uses no solution and improves the visi-
bility. Muto et al. (8,9,16) reported that both a well-
demarcated brownish area and an irregular microvascular
pattern are typical characteristics of the superﬁcial squamous
cell carcinoma in the head and neck region. In this study, we
evaluated the lesion according to these two endoscopic
characteristics, and we were able to conﬁrm 64% (16/25) of
the lesions in the suspicious cancerous area as squamous cell
carcinoma. This positive rate is better than that from a
random biopsy ( 10%). Finally, possible primary cancer
could be detected in 35% (16/46) of the patients. These
results indicate that NBI should be applied when surveying
the primary site in patients with PUCLNM. Moreover, it is
not impossible to detect cancerous lesion only using white-
light endoscopy by trained endoscopist but NBI endoscopy
is very easy for beginners to detect lesion.
Nine of 16 patients underwent surgery or endoscopic
resection of the primary site and subsequent lymph node dis-
section. In such cases, post-operative whole-neck radiation is
one treatment option (13–15). However, the indications for
post-operative radiation therapy for PUCLNM are still con-
troversial because these patients are at high risk for develop-
ing metachronous multiple cancers in the head and neck
region (16). If they received radiation therapy as a post-
operative radiation therapy, there is no radiotherapy treat-
ment option for the later appearance of a metachronously
developed second primary cancer in the head and neck
region (14–16). The clinician must thus plan the post-
operative radiation therapy carefully.
We cannot conclude with certainty whether the lesions
detected by NBI were the true primary sites unless we ident-
ify their clonality. As a next step, we will compare the clon-
ality of both primary sites and metastatic lymph nodes. In
this study, at least, histological assessment showed the same
histological features of the primary site and metastatic lymph
Figure 2. (A–D) Endoscopic ﬁndings. Conventional white-light image (A), narrow-band imaging (NBI) image (B), magnifying conventional white-light
image (C) and magnifying the NBI images (D). NBI detected a well-demarcated brownish area in the uvula to right anterior palatine arch (B). In contrast, con-
ventional white-light image was difﬁcult to visualize the cancerous lesion (A). Magnifying the observation with NBI revealed an irregular microvascular
pattern inside the lesion (D).
540 Usefulness of NBI for detection of primary site in the patients with PUCLNMnode. Clinically, histological accordance would be enough to
consider whether the lesion is primary.
Although we could not evaluate the depth of invasion in
all patients, we know that micro-invasive cancer can metas-
tasize to the lymph node. The risk of lymph node metastasis
of superﬁcial squamous cell carcinoma is unknown, but col-
lection of data from a large number of cases should help
clarify this.
In conclusion, our data indicate that NBI has the potential
to identify primary cancer in patients with PUCLNM.
Identiﬁcation of the primary site provides helpful infor-
mation for deciding on the treatment strategy.
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